Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects.
Pharmacokinetics and pharmacodynamics of IFN-beta 1a in healthy volunteers.
Is No Evidence of Disease Activity a Realistic Goal for Patients With Multiple Sclerosis?
Dimethyl fumarate induces apoptosis of hematopoietic tumor cells via inhibition of NF-κB nuclear translocation and down-regulation of Bcl-xL and XIAP.
Potassium channel KIR4.1 as an immune target in multiple sclerosis.
Relationship between neuromuscular and perceived fatigue and locomotor performance in patients with multiple sclerosis.
Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial.
Assessment of cancer risk with β-interferon treatment for multiple sclerosis.
Sox10 Expression in Goldfish Retina and Optic Nerve Head in Controls and after the Application of Two Different Lesion Paradigms.
A comparison of phase imaging and quantitative susceptibility mapping in the imaging of multiple sclerosis lesions at ultrahigh field.
Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome.
Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
WT1 and interferon-β-vitamin D association in MS: a longitudinal study.
EBNA1 antigen-specific CD8+ T cells in cerebrospinal fluid of patients with multiple sclerosis.
Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome.
Emerging Concepts on the Gut Microbiome and Multiple Sclerosis.
Primary Progressive MS evolving from Radiologically Isolated Syndrome.
International Joint Israel-Greek-Italian Neuroimmunological meeting
Treatment with Trichuris suis soluble products during monocyte-to-macrophage differentiation reduces inflammatory responses through epigenetic remodeling.
Reduction of CD8(+) T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate.
Altered intra- and interregional synchronization in relapsing-remitting multiple sclerosis: a resting-state fMRI study.
Opinion: Focus on preclinical sex differences will not address women's and men's health disparities.
Teriflunomide in multiple sclerosis: Added benefit not proven
Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain.
Retinyl Palmitate Supplementation Modulates T-bet and Interferon Gamma Gene Expression in Multiple Sclerosis Patients.

Pages